Martin Brenner - 22 Jun 2023 Form 4 Insider Report for iBio, Inc. (IBIO)

Role: Chief Executive Officer and Chief Scientific Officer
Signature: /s/ Martin Brenner
Issuer symbol: IBIO
Transactions as of: 22 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 27 Jun 2023, 08:12:15 UTC
Previous filing: 22 Jun 2023
Next filing: 13 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IBIO	Common Stock	Disposed to Issuer	$0	-75,833	-30%	$0.000000	177,578	22 Jun 2023	Direct	F1
transaction	IBIO	Common Stock	Award	$0	+75,833	+43%	$0.000000	253,411	26 Jun 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 75,833 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 75,833 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan") that expired prior to vesting.
F2	Consists of 75,833 shares of the Company's common stock, represented by 75,833 RSUs granted under the Company's 2020 Plan. Each RSU represents a contingent right to receive one share of Common Stock. The 75,833 RSUs vest pro rata over a seven-month period, such vesting to terminate if Dr. Brenner is no longer the Company's Chief Executive Officer

Remarks:

Chief Executive Officer and Chief Scientific Officer